相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions
Marisa P. McGinley et al.
LANCET (2021)
Sphingolipid metabolism as a marker of hepatotoxicity in drug-induced liver injury
Linhao Li et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2020)
Perturbed Lipidomic Profiles in Rats With Chronic Cerebral Ischemia Are Regulated by Xiao-Xu-Ming Decoction
Zhixin Jia et al.
FRONTIERS IN PHARMACOLOGY (2019)
CerS6-Derived Sphingolipids Interact with Mff and Promote Mitochondria! Fragmentation in Obesity
Philipp Hammerschmidt et al.
CELL (2019)
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis
Bhagirath Chaurasia et al.
SCIENCE (2019)
Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease
Meng Jiang et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Sphingosine 1-phosphate: Lipid signaling in pathology and therapy
Andreane Cartier et al.
SCIENCE (2019)
Role of Ceramidases in Sphingolipid Metabolism and Human Diseases
Farzana Parveen et al.
CELLS (2019)
Non-alcoholic fatty liver disease: Insights from sphingolipidomics
David J. Montefusco et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Tissue metabolomic profiling to reveal the therapeutic mechanism of reduning injection on LPS-induced acute lung injury rats
Zhili Xiong et al.
RSC ADVANCES (2018)
Combining Deep Sequencing, Proteomics, Phosphoproteomics, and Functional Screens To Discover Novel Regulators of Sphingolipid Homeostasis
Nicolas Lebesgue et al.
JOURNAL OF PROTEOME RESEARCH (2017)
Sphingolipids and glycerophospholipids - The ying and yang of lipotoxicity in metabolic diseases
S. Rodriguez-Cuenca et al.
PROGRESS IN LIPID RESEARCH (2017)
Application of iTRAQ-Based Quantitative Proteomics Approach to Identify Deregulated Proteins Associated with Liver Toxicity Induced by Polygonum Multiflorum in Rats
Longfei Lin et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Strategy for Hepatotoxicity Prediction Induced by Drug Reactive Metabolites Using Human Liver Microsome and Online 2D-Nano-LC-MS Analysis
Yue Zhuo et al.
ANALYTICAL CHEMISTRY (2017)
The Anti-hyperlipidemia Effects of Raw Polygonum multiflorum Extract in Vivo
Zhong Xian et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2017)
Profile and quantification of human stratum corneum ceramides by normal-phase liquid chromatography coupled with dynamic multiple reaction monitoring of mass spectrometry: development of targeted lipidomic method and application to human stratum corneum of different age groups
Zhi-Xin Jia et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2016)
Hepatobiliary and pancreatic: Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients
Yun Zhu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: A review
Longfei Lin et al.
JOURNAL OF ETHNOPHARMACOLOGY (2015)
SGK-1 protects kidney cells against apoptosis induced by ceramide and TNF-α
D. Pastore et al.
CELL DEATH & DISEASE (2015)
Review of clinical studies of Polygonum multiflorum Thunb. and its isolated bioactive compounds
Guy-Armel Bounda et al.
PHARMACOGNOSY RESEARCH (2015)
Eighteen cases of liver injury following ingestion of Polygonum multiflorum
Huihui Dong et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2014)
Ablation of Very Long Acyl Chain Sphingolipids Causes Hepatic Insulin Resistance in Mice Due to Altered Detergent-Resistant Membranes
Joo-Won Park et al.
HEPATOLOGY (2013)
Chemical characterization and immunostimulatory effects of a polysaccharide from Polygoni Multiflori Radix Praeparata in cyclophosphamide-induced anemic mice
Qin Chen et al.
CARBOHYDRATE POLYMERS (2012)
Toxicity of raw and processed roots of Polygonum multiflorum
Xiaoqing Wu et al.
FITOTERAPIA (2012)
SPHINGANINE-1-PHOSPHATE ATTENUATES BOTH HEPATIC AND RENAL INJURY INDUCED BY HEPATIC ISCHEMIA AND REPERFUSION IN MICE
Sang Won Park et al.
SHOCK (2010)
Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease
Alfred H. Merrill et al.
JOURNAL OF LIPID RESEARCH (2009)
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
Anna Ludovica Fracanzani et al.
HEPATOLOGY (2008)
Acute hepatitis associated with the use of an herbal supplement (Polygonum multiflorum) mimicking iron-overload syndrome
Ashley R. Laird et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
The current state of serum biomarkers of hepatotoxicity
Josef Ozer et al.
TOXICOLOGY (2008)
Sphingolipid signalling and liver diseases
Montserrat Mari et al.
LIVER INTERNATIONAL (2007)
Ceramide 1-phosphate/ceramide, a switch between life and death
Antonio Gomez-Munoz
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
TNF-receptor I defective in internalization allows for cell death through activation of neutral sphingomyelinase
Jens Neumeyer et al.
EXPERIMENTAL CELL RESEARCH (2006)
Dihydroceramide hinders ceramide channel formation: Implications on apoptosis
J. Stiban et al.
APOPTOSIS (2006)
Mechanisms of liver injury.: I.: TNF-α-induced liver injury:: role of IKK, JNK, and ROS pathways
RF Schwabe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Acidic sphingomyelinase downregulates the liver-specific methionine adenosyltransferase 1A, contributing to tumor necrosis factor-induced lethal hepatitis
M Marí et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values
P Mofrad et al.
HEPATOLOGY (2003)
Long-term administration of Polygonum multiflorum Thunb. reduces cerebral ischemia-induced infarct volume in gerbils
YC Chan et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2003)
分享论文
